12 January 2007

Drug makers opening up?

Since pharmaceutical companies have been pressured to enter studies in a US government registry, they have done a better job of providing important research information.

Since medical journals started to pressure pharmaceutical companies to enter studies in a US government registry, drug makers have done a better job of providing important information about their research, says an editorial published Thursday in the New England Journal of Medicine.

The editorial said that 8 percent of the 2 983 studies added to the federal registry in 2006 did not describe key outcomes, such as deaths or cholesterol levels, being measured in the trials. In previous years, the rate was 26 percent, the Associated Press reported.

The US federal registry was launched in 2000 but there was only limited drug industry participation until late 2004, when the members of the International Committee on Medical Journal Editors said they'd only publish studies that were signed into the registry in the early stages, the AP reported.

The committee made the move, in part, to prevent drug makers from trying to hide the findings of trials that produced unfavourable results. – (HealthDayNews)

Read more:
Research Centre

January 2007


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Mental health & your work »

How open are you about mental illness in the workplace?

Mental health in the workplace – what you can do to help

If you know that one of your colleagues suffers from a mental illness, would you be able to help them at work? Maligay Govender offers some helpful mental health "first aid" tips.

Sleep & You »

Sleep vs. no sleep Diagnosis of insomnia

6 things that are sabotaging your sleep

Kick these shut-eye killers to the kerb and make your whole life better – overnight.